A Circulating MicroRNA Signature Capable of Assessing the Risk of Hepatocellular Carcinoma in Cirrhotic Patients

With the availability of potent antiviral therapies, complete suppression of hepatitis B virus (HBV) replication and total eradication of hepatitis C virus (HCV) can now be achieved. Despite these advances, hepatocellular carcinoma (HCC) still develops in a substantial proportion of cirrhotic patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Ya-Hui, Liang, Kung-Hao, Chien, Rong-Nan, Hu, Tsung-Hui, Lin, Kwang-Huei, Hsu, Chao-Wei, Lin, Chih-Lang, Pan, Tai-Long, Ke, Po-Yuan, Yeh, Chau-Ting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5428873/
https://www.ncbi.nlm.nih.gov/pubmed/28364124
http://dx.doi.org/10.1038/s41598-017-00631-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5428873/
https://www.ncbi.nlm.nih.gov/pubmed/28364124
http://dx.doi.org/10.1038/s41598-017-00631-9

Ejemplares similares